Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

23

Revenue 2014

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

US biotech Translate Bio appoints Daniella Beckman

US biotech Translate Bio appoints Daniella Beckman

She has also held various finance positions at Coley Pharmaceuticals - which was acquired by Pfizer in 2008 - and Biogen Idec.

Voyager Therapeutics appoints Matthew Ottmer as chief operating officer

Voyager Therapeutics appoints Matthew Ottmer as chief operating officer Prior to Momenta, Ottmer spent 16 years at Biogen in a variety of leadership roles including senior vice president, strategy and emerging businesses, head of Tysabri business, chief of staff to ... the chief executive officer and president of Syntonix

Deal Watch May 2017

Two pre phase 2 molecules to treat neuro-degenerative disease have been licensed to Biogen and Roche for a combined $1.085bn. ... BMS. Biogen (US). Licence. Anti-tau antibody pre phase 2 for  progressive supranuclear palsy.

Life lessons

Life lessons That’s what explains the rise of companies like Roche, Gilead and Biogen and the relative struggles of Pfizer and GSK, among others.

Biogen says trial extension data keep Alzheimer's drug on track

Biogen says trial extension data keep Alzheimer's drug on track Biogen says trial extension data keep Alzheimer's drug on track. Releases updated results from the PRIME trial of anti-amyloid drug aducanumab. ... Biogen has continued to drip feed positive data on its Alzheimer's candidate aducanumab, and now says a

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics